Latest Insider Transactions at Medtronic PLC (MDT)
This section provides a real-time view of insider transactions for Medtronic PLC (MDT). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Medtronic plc to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Medtronic plc's insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Aug 03
2015
|
Richard Kuntz SVP & Chief Medical & Science |
BUY
Grant, award, or other acquisition
|
Direct |
10,257
+8.81%
|
-
|
Aug 03
2015
|
Bradley E Lerman SVP General Counsel & Corp Sec |
BUY
Grant, award, or other acquisition
|
Direct |
11,966
+20.19%
|
-
|
Aug 03
2015
|
Geoffrey Martha Chairman and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
9,830
+24.87%
|
-
|
Aug 03
2015
|
Carol A Surface EVP, Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,547
+10.1%
|
-
|
Aug 01
2015
|
Geoffrey Martha Chairman and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,767
-15.94%
|
$293,826
$78.39 P/Share
|
Jul 30
2015
|
Geoffrey Martha Chairman and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,126
-8.25%
|
$165,828
$78.28 P/Share
|
Jul 30
2015
|
Omar Ishrak Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct |
37,160
-7.03%
|
$2,898,480
$78.28 P/Share
|
Jul 30
2015
|
Michael J Coyle EVP & Group Pres, Cardiac&Vasc |
SELL
Payment of exercise price or tax liability
|
Direct |
9,684
-11.65%
|
$755,352
$78.28 P/Share
|
Jul 30
2015
|
Richard Kuntz SVP & Chief Medical & Science |
SELL
Payment of exercise price or tax liability
|
Direct |
5,277
-5.22%
|
$411,606
$78.28 P/Share
|
Jul 30
2015
|
Gary Lee Ellis EVP & Global Ops and IT |
SELL
Payment of exercise price or tax liability
|
Direct |
10,554
-6.36%
|
$823,212
$78.28 P/Share
|
Jul 28
2015
|
Bradley E Lerman SVP General Counsel & Corp Sec |
SELL
Payment of exercise price or tax liability
|
Direct |
7,799
-18.08%
|
$600,523
$77.47 P/Share
|
Jul 14
2015
|
Carol A Surface EVP, Chief HR Officer |
SELL
Open market or private sale
|
Direct |
13,722
-16.95%
|
$1,029,150
$75.83 P/Share
|
Jul 14
2015
|
Carol A Surface EVP, Chief HR Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,239
+9.24%
|
$469,623
$57.65 P/Share
|
Jun 13
2015
|
Omar Ishrak Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct |
30,195
-5.43%
|
$2,264,625
$75.52 P/Share
|
Jun 10
2015
|
Richard H Anderson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,440
+4.89%
|
$304,640
$57.0 P/Share
|
Apr 27
2015
|
Richard H Anderson Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,950
+2.02%
|
-
|
Apr 27
2015
|
Craig Arnold Director |
BUY
Grant, award, or other acquisition
|
Direct |
563
+3.46%
|
-
|
Apr 27
2015
|
Scott C Donnelly Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,950
+20.79%
|
-
|
Apr 27
2015
|
Michael O Leavitt Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,950
+10.11%
|
-
|
Apr 27
2015
|
Elizabeth G Nabel Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,230
+40.7%
|
-
|
Apr 27
2015
|
Shirley A Jackson Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,950
+3.11%
|
-
|
Apr 27
2015
|
Randall J Hogan Director |
BUY
Grant, award, or other acquisition
|
Direct |
563
+3.5%
|
-
|
Apr 27
2015
|
James T Lenehan Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,950
+2.69%
|
-
|
Apr 27
2015
|
Denise M Oleary Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,950
+2.25%
|
-
|
Apr 27
2015
|
Kendall J Powell Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,950
+4.36%
|
-
|
Apr 27
2015
|
Robert C Pozen Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,950
+1.89%
|
-
|
Apr 27
2015
|
Preetha Reddy Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,950
+15.29%
|
-
|
Apr 06
2015
|
Richard Kuntz SVP & Chief Medical & Science |
SELL
Open market or private sale
|
Direct |
31,768
-23.87%
|
$2,446,136
$77.39 P/Share
|
Apr 06
2015
|
Richard Kuntz SVP & Chief Medical & Science |
BUY
Exercise of conversion of derivative security
|
Direct |
35,447
+12.51%
|
$1,949,585
$55.11 P/Share
|
Mar 25
2015
|
Gary Lee Ellis EVP & Global Ops and IT |
SELL
Open market or private sale
|
Direct |
43,183
-20.74%
|
$3,325,091
$77.81 P/Share
|
Mar 25
2015
|
Gary Lee Ellis EVP & Global Ops and IT |
BUY
Exercise of conversion of derivative security
|
Direct |
37,011
+15.09%
|
$2,072,616
$56.74 P/Share
|
Mar 18
2015
|
Hoedt Rob Ten EVP and Pres. Global Regions |
SELL
Open market or private sale
|
Direct |
7,619
-25.4%
|
$586,663
$77.41 P/Share
|
Mar 13
2015
|
Omar Ishrak Executive Chairman |
SELL
Open market or private sale
|
Direct |
20,000
-3.48%
|
$1,520,000
$76.24 P/Share
|
Feb 26
2015
|
Denise M Oleary Director |
SELL
Open market or private sale
|
Direct |
368
-0.9%
|
$28,704
$78.85 P/Share
|
Feb 19
2015
|
Christopher J O Connell EVP & GroupPres Restora Therap |
SELL
Open market or private sale
|
Direct |
29,791
-24.21%
|
$2,323,698
$78.17 P/Share
|
Feb 19
2015
|
Christopher J O Connell EVP & GroupPres Restora Therap |
BUY
Exercise of conversion of derivative security
|
Direct |
29,791
+11.46%
|
$1,251,222
$42.47 P/Share
|
Feb 18
2015
|
Christopher J O Connell EVP & GroupPres Restora Therap |
SELL
Open market or private sale
|
Direct |
20,570
-18.07%
|
$1,604,460
$78.28 P/Share
|
Feb 18
2015
|
Christopher J O Connell EVP & GroupPres Restora Therap |
BUY
Exercise of conversion of derivative security
|
Direct |
18,723
+14.12%
|
$674,028
$36.24 P/Share
|
Feb 18
2015
|
Bryan C Hanson EVP, President, MITG |
BUY
Grant, award, or other acquisition
|
Direct |
19,109
+11.57%
|
-
|
Jan 26
2015
|
Richard Kuntz SVP & Chief Medical & Science |
BUY
Grant, award, or other acquisition
|
Direct |
97,651
+50.0%
|
-
|
Jan 26
2015
|
Denise M Oleary Director |
BUY
Grant, award, or other acquisition
|
Direct |
40,737
+50.0%
|
-
|
Jan 26
2015
|
Michael O Leavitt Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,033
+50.0%
|
-
|
Jan 26
2015
|
Bradley E Lerman SVP General Counsel & Corp Sec |
BUY
Grant, award, or other acquisition
|
Direct |
42,459
+50.0%
|
-
|
Jan 26
2015
|
Scott C Donnelly Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,986
+50.0%
|
-
|
Jan 26
2015
|
Scott C Donnelly Director |
BUY
Grant, award, or other acquisition
|
Indirect |
245
+50.0%
|
-
|
Jan 26
2015
|
Hoedt Rob Ten EVP and Pres. Global Regions |
BUY
Grant, award, or other acquisition
|
Direct |
29,991
+50.0%
|
-
|
Jan 26
2015
|
Richard H Anderson Director |
BUY
Grant, award, or other acquisition
|
Indirect |
7,305
+50.0%
|
-
|
Jan 26
2015
|
Richard H Anderson Director |
BUY
Grant, award, or other acquisition
|
Direct |
45,549
+50.0%
|
-
|
Jan 26
2015
|
Omar Ishrak Executive Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
574,395
+50.0%
|
-
|
Jan 26
2015
|
Kendall J Powell Director |
BUY
Grant, award, or other acquisition
|
Indirect |
3,000
+50.0%
|
-
|